- Home
- CEV vs VRCA Comparison
CEV vs VRCA Comparison
Compare CEV & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- VRCA
- Stock Information
- Founded
- CEV 1999
- VRCA 2013
- Country
- CEV United States
- VRCA United States
- Employees
- CEV N/A
- VRCA N/A
- Industry
- CEV Finance/Investors Services
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- CEV Finance
- VRCA Health Care
- Exchange
- CEV Nasdaq
- VRCA Nasdaq
- Market Cap
- CEV 71.8M
- VRCA 58.0M
- IPO Year
- CEV N/A
- VRCA 2018
- Fundamental
- Price
- CEV $9.62
- VRCA $0.49
- Analyst Decision
- CEV
- VRCA Hold
- Analyst Count
- CEV 0
- VRCA 5
- Target Price
- CEV N/A
- VRCA $6.00
- AVG Volume (30 Days)
- CEV 19.6K
- VRCA 614.0K
- Earning Date
- CEV 01-01-0001
- VRCA 05-12-2025
- Dividend Yield
- CEV 4.23%
- VRCA N/A
- EPS Growth
- CEV N/A
- VRCA N/A
- EPS
- CEV 0.36
- VRCA N/A
- Revenue
- CEV N/A
- VRCA $7,566,000.00
- Revenue This Year
- CEV N/A
- VRCA $127.58
- Revenue Next Year
- CEV N/A
- VRCA $88.06
- P/E Ratio
- CEV $29.36
- VRCA N/A
- Revenue Growth
- CEV N/A
- VRCA 47.66
- 52 Week Low
- CEV $8.83
- VRCA $0.38
- 52 Week High
- CEV $10.91
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- CEV 36.08
- VRCA 46.71
- Support Level
- CEV $9.31
- VRCA $0.38
- Resistance Level
- CEV $10.19
- VRCA $0.59
- Average True Range (ATR)
- CEV 0.13
- VRCA 0.09
- MACD
- CEV -0.03
- VRCA 0.01
- Stochastic Oscillator
- CEV 35.23
- VRCA 40.52
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.